Financials

News Discussions Technicals Forecast Seasonals

50J fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to KANGJI MED.HLDS DL-,00001 operating, investing, and financing activities

50J free cash flow for H2 24 is 43.5 M EUR. For 2024, 50J free cash flow was 79.74 M EUR and operating cash flow was 87.19 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—